The Belviq lawsuit claims that Eisai knew the risks and side effects of this prescription pill, yet the company sold it to hundreds of thousands of people, despite the known risks. In the lawsuit, plaintiffs are seeking damages for false advertising, deceptive acts, and unjust enrichment, as well as conversion and intentional interference with life. The company was also liable for millions of patients’ deaths, and tens of thousands of lawsuits have been filed since the drug was withdrawn from the market.
Contents
Cancer risk
The FDA warned patients about the Belviq and cancer risk link but did not specify what type of cancer was increased and how much. The clinical trial results, however, suggested that the drug may increase the risk of cancer. While the exact cause of cancer remains unknown, the researchers found that patients taking lorcaserin (the active ingredient in Belviq) developed more tumors than those who took a placebo. As a result, the drug has been pulled from the market.
A 2011 FDA study showed that the drug was associated with increased cancer risk in humans. The study involved 12,000 women and was approved in 2012. A number of side effects were reported. The most common were headaches, dizziness, and fatigue. Researchers also found that the risk of cancer increased as the drug was used longer. Because of this, the drug has been the subject of many Belviq Class Action Lawsuit and is currently being recalled by the FDA.
Heart conditions
A recent Belviq cardiovascular study found that patients were at risk of three types of cancer. Depending on the stage of the disease, colorectal, pancreatic, and lung cancer can cause discomfort and even death. Although the onset of these conditions is rare, they can be dangerous. The condition begins with benign polyps in the colon and rectum. It is treated with surgery and can cause painful and unpleasant symptoms. The average five-year survival rate is around 63%.
The FDA required Eisai Inc. to conduct additional studies to determine whether Belviq caused heart problems. The results of these trials prompted the company to recall the medication. Moreover, the company was ordered to conduct long-term trials on cardiovascular side effects. The CAMELLIA-TIMI 61 trial involved 12,000 patients over five years. However, the study’s results were not conclusive.
Memory loss
If you or a loved one has suffered from memory loss or other side effects after taking Belviq, you may have a right to file a lawsuit. The lawsuit alleges that the pharmaceutical company violated the terms of an implied warranty or failed to warn doctors of the risks of developing malignancies.
While you may want to file the lawsuit yourself, it is best to consult with a lawyer before making any final decisions. If you believe that you are a potential plaintiff, you should consult with an experienced product liability attorney as soon as possible. The lawyer will review your case and advise you on how to proceed with your claim.
The complaint was filed in U.S. District Court in White Plains, New York, against the pharmaceutical company Arena Pharmaceuticals Inc., the company that developed Belviq’s active ingredient, lorcaserin.
The lawsuit also names CVS Health Co., the pharmacy chain from which the plaintiff purchased Belviq. The plaintiff, Barbara Z., bought Belviq from CVS Health Co. in 2013. The lawsuit also alleges that the drug caused rare cancerous tumors in rats in 2007.
Memory loss caused by Belviq
If you are one of the many people who have experienced the devastating side effects of Belviq, you may be able to pursue a compensation lawsuit. This lawsuit was filed in U.S. District Court in White Plains, New York, and names CVS Health Co., Arena Pharmaceuticals Inc., and the manufacturer of lorcaserin, the active ingredient in Belviq. The complaint alleges that lorcaserin caused rare cancerous tumors in lab rats when it was first introduced to the market in 2007.
If you think that you may qualify for a Belviq lawsuit, it is critical to seek legal help as soon as possible. You must first understand the process of civil litigation. Depending on your state’s laws, you can file a lawsuit for wrongful death if the other person has died while taking Belviq. In most states, there is a statute of limitations. In order to file your lawsuit, you must do so before the statute of limitations expires.
Increased risk of cancer from Belviq
A recent study found a possible link between Belviq and an increased risk of cancer in patients with lung cancer. Lung cancer is a very common form of cancer that occurs in smokers, but it can also occur in non-smokers. Colorectal cancer is usually painful and uncomfortable, and it starts with a harmless polyp in the rectum or colon. In its later stages, it can spread to other parts of the body, including the brain and bones.
After a review of the data from the study, the FDA formally requested the drug manufacturer to withdraw the drug from the market. Eisai Inc., the company that produces Belviq, voluntarily recalled the drug until further investigation could be done.
The agency also ordered the manufacturer to conduct a clinical trial to measure the cancer risk associated with Belviq. Interestingly, the manufacturer of Belviq is still working on assessing the data from this trial.